[go: up one dir, main page]

AU3283789A - Immunogenic glycoproteins of human cytomegalovirus - Google Patents

Immunogenic glycoproteins of human cytomegalovirus

Info

Publication number
AU3283789A
AU3283789A AU32837/89A AU3283789A AU3283789A AU 3283789 A AU3283789 A AU 3283789A AU 32837/89 A AU32837/89 A AU 32837/89A AU 3283789 A AU3283789 A AU 3283789A AU 3283789 A AU3283789 A AU 3283789A
Authority
AU
Australia
Prior art keywords
human cytomegalovirus
glycoproteins
immunogenic
immunogenic glycoproteins
cytomegalovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32837/89A
Inventor
Richard C. Gehrz
Bruce E. Kari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital Inc
Original Assignee
Childrens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Inc filed Critical Childrens Hospital Inc
Publication of AU3283789A publication Critical patent/AU3283789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089Cytomegalovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU32837/89A 1988-02-22 1989-01-25 Immunogenic glycoproteins of human cytomegalovirus Abandoned AU3283789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15838988A 1988-02-22 1988-02-22
US158389 1993-11-29

Publications (1)

Publication Number Publication Date
AU3283789A true AU3283789A (en) 1989-09-06

Family

ID=22567884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32837/89A Abandoned AU3283789A (en) 1988-02-22 1989-01-25 Immunogenic glycoproteins of human cytomegalovirus

Country Status (5)

Country Link
EP (1) EP0403541A4 (en)
JP (1) JPH03502799A (en)
KR (1) KR900700509A (en)
AU (1) AU3283789A (en)
WO (1) WO1989007615A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
US5807557A (en) * 1994-07-25 1998-09-15 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
CA2212682A1 (en) 1995-02-10 1996-08-15 Worcester Foundation For Experimental Biology, Inc. Delivery of exogenous compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a

Also Published As

Publication number Publication date
WO1989007615A1 (en) 1989-08-24
EP0403541A1 (en) 1990-12-27
JPH03502799A (en) 1991-06-27
EP0403541A4 (en) 1991-01-09
KR900700509A (en) 1990-08-13

Similar Documents

Publication Publication Date Title
AU4285889A (en) Preparation of catheter
AU7746487A (en) Surgical prosthesis
AU3522189A (en) Preparation of lower polyhydric alcohols
AU2189588A (en) Artificial skin
AU5181190A (en) Multifunctional facial tissue
AU3437389A (en) Process of preparing hydroxylapatite
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU3967889A (en) Immunogenic glycoproteins of human cytomegalovirus gcii
AU5405390A (en) Early envelope glycoproteins of human cytomegalovirus (hmcv)
AU613543B2 (en) Preparation of halofluorobenzenes
AU7412787A (en) Glycoprotein of human cytomegalovirus
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU3283789A (en) Immunogenic glycoproteins of human cytomegalovirus
GB2220000B (en) Preparation of iodoalkynyl carbamates
NZ227594A (en) Human interleukin-1alpha and preparations thereof
IL91422A0 (en) Cosmetic preparation
AU3434489A (en) Skin treatment formulations
AU3549489A (en) Human gm-csf variants
AU6357890A (en) Expression of alpha-macroglobulins
AU5050490A (en) Human monocyte-macrophage-csf preparations
AU4958690A (en) Preparation of 2-halofluorobenzene
AU3048689A (en) Immunogenic peptides
AU584704B2 (en) Ocular prosthesis
AU6966891A (en) Detection of human adenovirus
AU3651689A (en) Cloning and expression of human tissue factor